These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15472164)

  • 1. Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations.
    Liu PY; Swerdloff RS; Veldhuis JD
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4789-96. PubMed ID: 15472164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
    Harman SM
    Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen deficiency and aging in men.
    Swerdloff RS; Wang C
    West J Med; 1993 Nov; 159(5):579-85. PubMed ID: 8279155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?
    Haren MT; Morley JE; Chapman IM; O'Loughlin PD; Wittert GA
    Climacteric; 2002 Mar; 5(1):15-25. PubMed ID: 11974555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
    Raynor MC; Carson CC; Pearson MD; Nix JW
    Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
    Meier C; Liu PY; Ly LP; de Winter-Modzelewski J; Jimenez M; Handelsman DJ; Seibel MJ
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3033-41. PubMed ID: 15181095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.
    Ly LP; Jimenez M; Zhuang TN; Celermajer DS; Conway AJ; Handelsman DJ
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4078-88. PubMed ID: 11549629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine aging in men. Andropause and somatopause.
    Anawalt BD; Merriam GR
    Endocrinol Metab Clin North Am; 2001 Sep; 30(3):647-69. PubMed ID: 11571935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone and the aging male.
    Tenover JL
    J Androl; 1997; 18(2):103-6. PubMed ID: 9154502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The decline of androgen levels in elderly men and its clinical and therapeutic implications.
    Kaufman JM; Vermeulen A
    Endocr Rev; 2005 Oct; 26(6):833-76. PubMed ID: 15901667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
    Miller KK; Biller BM; Beauregard C; Lipman JG; Jones J; Schoenfeld D; Sherman JC; Swearingen B; Loeffler J; Klibanski A
    J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
    Young NR; Baker HW; Liu G; Seeman E
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB; Rajfer J
    Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
    McGill JJ; Shoskes DA; Sabanegh ES
    Cleve Clin J Med; 2012 Nov; 79(11):797-806. PubMed ID: 23125330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone supplementation: why and for whom?
    Gooren L
    Aging Male; 2003 Sep; 6(3):184-99. PubMed ID: 14628499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deficiency in women.
    Miller KK
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2395-401. PubMed ID: 11397829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.